FDA Grand Rounds - The PATH from Data to Action: Key Findings from the Population Assessment of Tobacco and Health (PATH) Study to Inform FDA’s Regulatory Activities

The Population Assessment of Tobacco and Health (PATH) Study, a national, longitudinal cohort study of tobacco use and health in the United States, is one of the first large tobacco research efforts undertaken by FDA Center for Tobacco Products (CTP) and National Institute of Health (NIH) after Congress gave FDA authority to regulate tobacco products in 2009. This presentation will share an overview and history of the PATH Study, evolution of the study design made over time in response to important changes in tobacco marketplace and regulatory environment and highlight how its designs and findings can inform tobacco regulatory science and public health.

For technical assistance please contact: Isaac.Miller@fda.hhs.gov